Antigenic and Molecular Evolution of the Vaccine Strain of Type 3 Poliovirus during the Period of Excretion by a Primary Vaccinee

References

1. Cann A. J., Stanway G., Hughes P. J., Minor P. D., Evans D. M. A., Schild G. C., Almond J. W. 1984; Reversion to virulence of the live attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Research 12:7787–7792
   [Google Scholar]
2. Crainic R., Couillin P., Blondel B., Cabau N., Bouse A., Horodniceanu F. 1983; Natural variation of poliovirus epitopes. Infection and Immunity 41:1217–1225
   [Google Scholar]
3. Dömök I., Magrath D. I. 1979; Guide to poliovirus isolation and serological techniques for poliomyelitis surveillance. WHO Offset Publication No. 46
   [Google Scholar]
4. Evans D. M. A., Minor P. D., Schild G. C., Almond J. W. 1983; Critical role of an eight amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature, London 304:459–462
   [Google Scholar]
5. Evans D. M. A., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V. 1985; A single nucleotide change in the 5ʹ non coding region of the genome of the Sabin type 3 poliovaccine is associated with increased neurovirulence. Nature, London 314:548–550
   [Google Scholar]
6. Ferguson M., Minor P. D., Magrath D. I., Yi-Hua Qui, Spitz M., Schild G. C. 1984; Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies. Journal of General Virology 65:197–201
   [Google Scholar]
7. Fox J. P., Gelfand H. M., Leblanc D. R., Potash L., Clemmer D. I., Laperta D. 1960; The spread of vaccine strains of poliovirus in the household and in the community in Southern Louisiana. International Poliomyelitis Conference (Copenhagen, 1960) 368–383
   [Google Scholar]
8. Fricks C. E., Icenogle J. P., Hogle J. M. 1985; Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. Journal of Virology 54:856–859
   [Google Scholar]
9. Hogle J. M., Chow M., Filman D. J. 1985; The three dimensional structure of poliovirus at 29 A resolution. Science 229:1358–1365
   [Google Scholar]
10. Kew O. M., Nottay B. K. 1984; Evolution of the oral polio vaccine strains in humans occurs by both mutation and intramolecular recombination. In Modern Approaches to Vaccines: Molecular and Chemical Basis of Virus Virulence and Immunogenecity pp. 357–362 Edited by Chanock R. M., Lerner R. A. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
11. kew O. M., Nottay B. K., Hatch M. H., Nakano J. H., Obijeski J. F. 1981; Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. Journal of General Virology 56:337–347
    [Google Scholar]
12. King A. M. Q., Mccahon D., Slade W. R., Newman J. W. I. 1982; Recombination in RNA. Cell 29:921–928
    [Google Scholar]
13. Kitamura N., Semler B. L., Rothberg P. G., Larsen G. R., Adler C. J., Dorner A. J., Emini E. A., Hanecak R., Lee J. L., Vander Werf S., Anderson C. W., Wimmer E. 1981; Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature, London 291:547–553
    [Google Scholar]
14. Minor P. D. 1980; Comparative biochemical studies of type 3 poliovirus. Journal of Virology 34:73–84
    [Google Scholar]
15. Minor P. D. 1982; Characterization of strains of type 3 poliovirus by oligonucleotide mapping. Journal of General Virology 59:307–317
    [Google Scholar]
16. Minor P. D., Schild G. C., Bootman J., Evans D. M. A., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A. J., Hauptmann R., Clarke L. -D., Mountford R. C., Almond J. W. 1983; Location and primary structure of a major antigenic site for poliovirus neutralization. Nature, London 301:674–679
    [Google Scholar]
17. Minor P. D., Evans D. M. A., Ferguson M., Schild G. C., Westrop G., Almond J. W. 1985; Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. Journal of General Virology 65:1159–1165
    [Google Scholar]
18. Nottay B. K., Kew O. M., Hatch M. H., Heyward J. T., Obijeski J. F. 1981; Molecular variation of type 1 vaccine related and wild polioviruses during replication in humans. Virology 108:405–423
    [Google Scholar]
19. Omata T., Kohara M., Abe S., Itoh H., Komatsu T., Arita M., Semler B. L., Wimmer E., Kuge S., Kameda A., Nomoto A. 1985; Construction of recombinant viruses between Mahoney and Sabin strains of type-1 poliovirus and their biological characteristics. In Vaccines 85: Molecular and Chemical Basis of Resistance to Parasitic, Bacterial, and Viral Diseases pp. 279–283 Edited by Lerner R. A. Chanock R. M., Brown F. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
20. Sabin A. B., Boulger L. R. 1973; History of Sabin attenuated poliovirus oral live vaccine strains. Journal of Biological Standardization 1:115–118
    [Google Scholar]
21. Toyoda H., Kohara M., Kataoka Y., Suganuma T., Omata T., Imura N., Nomoto A. 1984; Complete nucleotide sequence of all three poliovirus serotype genomes: implications for genetic relationship, gene function and antigenic determinants. Journal of Molecular Biology 124:561–585
    [Google Scholar]
22. Yoneyama T., Hagiwara H., Hara M., Shimojo H. 1982; Alteration in oligonucleotide fingerprint patterns of the viral genome of poliovirus type 2 isolated from paralytic patients. Injection and Immunity 3746–53
    [Google Scholar]